Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Beclomethasone Dipropionate/Formoterol Fumarate
DRUG
2 trials
Sponsors
Alfredo Antonio Chetta
, Chiesi Farmaceutici S.p.A.
Conditions
Asthma
Chronic Obstructive Pulmonary Disease
Phase 3
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
Completed
NCT05292586
Chiesi Farmaceutici S.p.A.
Asthma
Start: 2022-08-31
End: 2024-06-24
Updated: 2026-07-20
Unknown Phase
The Effect of Beclomethasone/Formoterol in Extra-fine Formulation on Quality of Life and SAD in COPD Patients.
Completed
NCT04421742
Alfredo Antonio Chetta
Chronic Obstructive Pulmonary Disease
Start: 2017-05-31
End: 2019-05-23
Updated: 2020-06-09
Related Papers
Improved lung function with beclomethasone/formoterol versus beclomethasone alone in asthma: the FORCE2 study.
2025-11-22
Improved lung function with beclomethasone/formoterol versus beclomethasone alone in asthma: the FORCE2 study
2025-01-01
Improved lung function with beclomethasone/formoterol versus beclomethasone alone in asthma: The FORCE2 study
2025-01-01
Improved lung function with beclomethasone/formoterol versus beclomethasone alone in asthma: the FORCE2 study
OPAL (Open@LaTrobe) (La Trobe University)
2025-01-01
Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD Patients
Pulmonary Therapy
2021-02-04
9 citations